Aurora Cannabis (ACB) Asset Writedowns and Impairment (2019 - 2025)

Aurora Cannabis (ACB) has reported Asset Writedowns and Impairment for 7 consecutive years, with -$381483.4 the latest figure, recorded in Q3 2025.

• Quarterly Asset Writedowns and Impairment fell 100.0% year-over-year to -$381483.4 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $11.6 billion (changed 0.03% YoY) and the FY2024 annual result came in at $10.6 million, up 164.41% from the prior year.
• Asset Writedowns and Impairment grew to -$381483.4 in Q3 2025 per ACB's latest filing, from -$405886.5 in the prior quarter.
• Over the last five years, Asset Writedowns and Impairment for ACB reached as high as $11.6 billion in Q3 2024 and fell as low as -$139.0 million in Q1 2022.
• A 5-year average of $832.7 million and a median of -$237900.3 in 2024 frame the typical range for Asset Writedowns and Impairment.
• Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment sank 3769.19% — and 2024, when it surged 1268899.46%.
• Year by year, Asset Writedowns and Impairment stood at $6.8 million in 2021, then sank by 975.09% to -$59.4 million in 2022, then jumped by 96.96% to -$1.8 million in 2023, then surged by 77.54% to -$405886.5 in 2024, then increased by 6.01% to -$381483.4 in 2025.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered -$381483.4, -$405886.5, and $11.6 billion for Q3 2025, Q4 2024, and Q3 2024 respectively.